skinny.

Latest / GK Daily Podcast

GK Daily Special Edition: The Antigen Switch — How One Injection Might End a Lifetime of Hepatitis B Pills

Picture a disease you've been managing since childhood, one pill every single morning for decades, with no real end in sight, every missed dose a small risk that the virus flares back up. That's the daily reality for more than a million people in the United States living with chronic hepatitis B, and for 240 million people worldwide. Yesterday, that calculus changed for at least some of them, when American regulators approved a drug built on a completely different idea: not suppressing the virus forever, but trying to shut it down for good, and letting people eventually walk away from...

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.